Phase I study of cellular therapy using ex vivo expanded natural killer cells from autologous peripheral blood mononuclear cells combined with rituximab-containing chemotherapy for relapsed CD20-positive malignant lymphoma patients
| Image |  |
|---|---|
| Description | scientific article published on 08 August 2019 |
| Author/s |
author: Kenjiro Mitsuhashi |
| Publication date | August 8, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |